Anika Therapeutics, Inc. (ANIK) — SC 13D/A Filings
All SC 13D/A filings from Anika Therapeutics, Inc.. Browse 2 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (2)
-
Caligan Partners Amends Anika Therapeutics Stake
— May 30, 2024 Risk: medium
Caligan Partners LP, an investment firm, has amended its Schedule 13D filing regarding Anika Therapeutics, Inc. on May 30, 2024. The filing indicates a change i -
Caligan Partners Amends Anika Therapeutics Stake
— Mar 6, 2024 Risk: medium
Caligan Partners LP, along with David Johnson and William Jellison, has amended their Schedule 13D filing regarding Anika Therapeutics, Inc. as of March 6, 2024
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX